TGF-β1/Smad3 Signaling Pathway Mediates T-2 Toxin-Induced Decrease of Type II Collagen in Cultured Rat Chondrocytes

Yang Li1, Ning Zou2, Jing Wang3

  • 1Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, China. yangli9295@hotmail.com.

Toxins
|November 9, 2017
PubMed

Insights

T-2 toxin damages articular cartilage by upregulating the TGF-β1/Smad3 pathway, increasing MMP13, and reducing type II collagen. This leads to chondrocyte apoptosis and cartilage damage.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Toxicology

Background:

  • T-2 toxin is known to cause articular cartilage damage.
  • The precise molecular mechanisms underlying T-2 toxin-induced chondrocyte damage are not fully understood.

Purpose of the Study:

  • To investigate the role of the transforming growth factor-beta 1 (TGF-β1)/Smad3 signaling pathway in T-2 toxin-induced chondrocyte damage.
  • To elucidate the molecular mechanisms of T-2 toxin's effects on articular cartilage.

Main Methods:

  • Primary rat chondrocytes were cultured and treated with T-2 toxin.
  • Cell viability and apoptosis were assessed.
  • Levels of type II collagen, TGF-β1, Smad3, ALK5, and matrix metalloproteinase 13 (MMP13) were measured at mRNA and protein levels.
  • Inhibitors of TGF-β1 and Smad3 were used to explore pathway involvement.

Main Results:

  • T-2 toxin reduced chondrocyte viability and increased apoptosis.
  • T-2 toxin decreased type II collagen production while upregulating TGF-β1, Smad3, ALK5, and MMP13.
  • Increased phosphorylation of Smad3 (P-Smad3) was observed.
  • TGF-β1 and Smad3 inhibitors partially reversed T-2 toxin's effects.
  • T-2 toxin promotes MMP13 via TGF-β1 signaling, leading to collagen II downregulation and chondrocyte damage.

Conclusions:

  • The TGF-β1/Smad3 signaling pathway is implicated in T-2 toxin-induced chondrocyte damage.
  • T-2 toxin-induced MMP13 upregulation contributes to type II collagen reduction and chondrocyte injury.
  • Smad3 may play a role in type II collagen degradation, independent of MMP13 regulation.